Ayal Hendel

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Natural Killer Cells

Signaling Pathway

Top Venues

Nature communications

International journal of molecular sciences

Science (New York, N.Y.)

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Vasyl Eisenberg, Shiran Hoogi, Erel Katzman, Nimrod Ben Haim, Raphaelle Zur-Toledano, Maria Radman, Yishai Reboh, Oranit Zadok, Iris Kamer, Jair Bar, Irit Sagi, Ayal Hendel, Cyrille J Cohen
Targeting Tumor-Associated Sialic Acids using Chimeric Switch Receptors based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells. Cancer immunology research (2024)
Guy Assa, Nechama Kalter, Michael Rosenberg, Avigail Beck, Oshry Markovich, Tanya Gontmakher, Ayal Hendel, Zohar Yakhini
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0. Nucleic acids research (2024)
Avishay Edri, Nimrod Ben-Haim, Astar Hailu, Nurit Brycman, Orit Berhani-Zipori, Julia Rifman, Sherri Cohen, Dima Yackoubov, Michael Rosenberg, Ronit Simantov, Hideshima Teru, Keiji Kurata, Kenneth Carl Anderson, Ayal Hendel, Aviad Pato, Yona Geffen
Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells. International journal of molecular sciences 24 (24) (2023)
Daniel Allen, Orli Knop, Bryan Itkowitz, Nechama Kalter, Michael Rosenberg, Ortal Iancu, Katia Beider, Yu Nee Lee, Arnon Nagler, Raz Somech, Ayal Hendel
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications. Nature communications 14 (1) (2023)
Avishay Edri, Nimrod Ben-Haim, Astar Hailu, Nurit Brycman, Orit Berhani-Zipori, Julia Rifman, Sherri Cohen, Dima Yackoubov, Michael Rosenberg, Ronit Simantov, Hideshima Teru, Keiji Kurata, Kenneth Carl Anderson, Ayal Hendel, Aviad Pato, Yona Geffen
Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells. International journal of molecular sciences 24 (24) (2023)
Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Yael Aylon, Rona Yaeger, Giulia Fontemaggi, Saptaparna Mukherjee, Martino Maddalena, Adi Avioz, Ortal Iancu, Giuseppe Mallel, Anat Gershoni, Inna Grosheva, Ester Feldmesser, Shifra Ben-Dor, Ofra Golani, Ayal Hendel, Giovanni Blandino, David P Kelsen, Yosef Yarden, Moshe Oren
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients. Nature communications 13 (1) (2022)
Eran Hodis, Elena Torlai Triglia, John Y H Kwon, Tommaso Biancalani, Labib R Zakka, Saurabh Parkar, Jan-Christian Hütter, Lorenzo Buffoni, Toni Marie Delorey, Devan Phillips, Danielle Dionne, Lan T Nguyen, Denis Schapiro, Zoltan Maliga, Connor A Jacobson, Ayal Hendel, Orit Rozenblatt-Rosen, Martin C Mihm, Levi A Garraway, Aviv Regev
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment. Science (New York, N.Y.) 376 (6592) (2022)
Ido Amit, Ortal Iancu, Alona Levy-Jurgenson, Gavin L Kurgan, Matthew S McNeill, Garrett R Rettig, Daniel Allen, Dor Breier, Nimrod Ben Haim, Yu Wang, Leon Anavy, Ayal Hendel, Zohar Yakhini
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data. Nature communications 12 (1) (2021)